<DOC>
	<DOCNO>NCT01924806</DOCNO>
	<brief_summary>A Pilot Study WoundWand™ Debridement Device Infection Prevention</brief_summary>
	<brief_title>A Pilot Study WoundWand™ Debridement Device Infection Prevention</brief_title>
	<detailed_description>The primary aim pilot study investigate difference bacterial content study wound may impact upon infection rate follow debridement WoundWand Debridement Device Standard Care ( SoC ) surgical ( sharp ) debridement . Additionally , clinical investigation evaluate reduction wound size post-debridement gather Health Economic data relating wound bed debridement WoundWand Debridement Device SoC .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Inclusion Criteria Subjects meet follow criterion may include clinical investigation , present ALL following : 1 . Subject able understand evaluation willing consent comply postdebridement visit procedure 2 . Age 18 year old . Subjects may either sex race skin type 3 . Subjects fulfil one follow criterion : 1. chronic wound ( ) level knee , define delay heal cellular senescence 2. acute wound ( ) result surgical procedure , laceration , abrasion trauma 3. diabetic foot ulcer ( ) 4. subject venous leg ulcer knee leg foot one document failure maximal medical therapy study wind &gt; 30 day compression bandage ( low elasticity , elastic , multilayered , elastic non elastic compression ) 4 . Subjects follow lab result within 30 day treatment : 1. serum albumin level &gt; 20g/L 2. clinically non significant result liver function test ( LFTs ) , serum glucose complete blood count ( CBC ) differential 5 . Subjects Braden Score ≥1314 ( Moderate Risk ) 6 . Subjects adequate arterial blood flow [ AnkleBrachial Index ( ABI ) &gt; 0.75 ] Exclusion Criteria Subjects exclude clinical investigation , present ANY following : 1 . Subjects tunnel wound 2 . Subject present active infection study wound , define purulence : 1 . Fever leukocytosis OR TWO follow : 2 . Malodor , pain tenderness , warmth , erythema , induration , swell , lymphangitis 3 . Infected bone diagnose image modality ( e.g. , Magnetic Resonance Imaging ( MRI ) and/or radiographic image ) 4 . Subjects whose study wind require debridement 5 . Cardiac pacemaker electronic implant ( ) 6 . Subjects irradiate , burn ischaemic wound history keloid 7 . Subjects vasculitis , nonreconstructive peripheral vascular disease , pyoderma gangrenosum , renal failure lymphoedema 8 . Subjects uncontrolled bleed disorder ( PT/PTT ) coagulopathy ( include hemophilia ) 9 . Subjects take treatment follow : 1 . Systemic corticosteroid 2 . Immunosuppressive agent ( ) 3 . Chemotherapy Radiation therapy 10 . Subjects deem require biologic dressing/ skin substitute 11 . Terminally ill subject 12 . Subjects immunodeficiency disorder interferes wound healing , include Acquired Immunodeficiency Syndrome ( AIDS ) know infect Human Immunodeficiency Virus ( HIV ) 13 . Subjects chronic skin condition psoriasis , etc . 14 . Subjects reside nurse home 15 . Subject physically mentally compromise ( e.g. , currently treat psychiatric disorder , senile dementia , Alzheimer 's disease , etc . ) extent Investigator judge subject unable unlikely remain compliant 16 . Subject pregnant and/or intend become pregnant clinical investigation period 17 . Subject documented evidence history ( e.g . liver test ) drug/alcohol abuse within 12 month prior enrollment clinical investigation entry 18 . Subject exclude received investigational therapy approve therapy investigational use within 30 day surgery 19 . Subject exclude planning participate another research study followup phase study 84 day study completion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>debridement</keyword>
	<keyword>post-debridement</keyword>
	<keyword>infection</keyword>
	<keyword>prevention</keyword>
	<keyword>wound</keyword>
	<keyword>wound tissue</keyword>
	<keyword>wound management</keyword>
	<keyword>WoundWand</keyword>
	<keyword>wound size reduction</keyword>
	<keyword>wound bed debridement</keyword>
	<keyword>WoundWand Debridement Device</keyword>
	<keyword>chronic wound</keyword>
	<keyword>delay healing</keyword>
	<keyword>cellular senescence</keyword>
	<keyword>acute wound</keyword>
	<keyword>diabetic foot ulcer</keyword>
	<keyword>venous leg ulcer</keyword>
	<keyword>radiofrequency debridement</keyword>
	<keyword>necrotic tissue</keyword>
	<keyword>wound healing</keyword>
	<keyword>skin</keyword>
</DOC>